Načítá se...
Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow
BACKGROUND: Coronary slow flow (CSF) is a special coronary microvascular disorder. The pathogenesis and effective therapeutics of CSF remain unclear. This study aimed to evaluate the global and regional functions of the left ventricle (LV) and investigate the efficacy of nicorandil in patients with...
Uloženo v:
| Vydáno v: | Coron Artery Dis |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323571/ https://ncbi.nlm.nih.gov/pubmed/25325437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCA.0000000000000179 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|